<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://neomed.omeka.net/items/browse?tags=Acne+Vulgaris%2F%2Adrug+therapy%2F%2Apsychology&amp;sort_field=Dublin+Core%2CCreator&amp;sort_dir=a&amp;output=omeka-xml" accessDate="2026-03-06T16:25:16-05:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="5100" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="63605">
              <text>&lt;a href="http://doi.org/10.3109/09546634.2011.643221" target="_blank" rel="noreferrer noopener"&gt;http://doi.org/10.3109/09546634.2011.643221&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Pages</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="63607">
              <text>26–34</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="56">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="63608">
              <text>1</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="57">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="63609">
              <text>23</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63597">
                <text>A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="63598">
                <text>The Journal of dermatological treatment</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63599">
                <text>2012</text>
              </elementText>
              <elementText elementTextId="63600">
                <text>2012-02</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63601">
                <text>Adult; Female; Humans; Male; Adolescent; Young Adult; Child; Severity of Illness Index; Quality of Life/*psychology; Double-Blind Method; *Patient Satisfaction; Drug Combinations; Acne Vulgaris/*drug therapy/*psychology; Adapalene; Benzoyl Peroxide/administration &amp; dosage/*therapeutic use; Dermatologic Agents/administration &amp; dosage/*therapeutic use; Naphthalenes/administration &amp; dosage/*therapeutic use</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63602">
                <text>Brodell Robert T; Schlosser Bethanee J; Rafal Elyse; Toth Darryl; Tyring Stephen; Wertheimer Albert; Kerrouche Nabil; Bucher Delphine</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63603">
                <text>INTRODUCTION: Acne has a significant negative impact on quality of life (QoL): lack of self-confidence, depressive symptoms and suicidal thoughts. The objective was to assess the impact of an initial and continued therapy in severe acne patients through patient-related outcomes (PRO). METHODS: In two sequential double-blind randomized studies, patients received either adapalene 0.1% and benzoyl peroxide 2.5% (A-BPO) or vehicle, associated with doxycycline 100 mg for 12 weeks. Patients having obtained at least a good improvement according to investigator global assessment were re-randomized for a 24-week therapy with</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="63604">
                <text>&lt;a href="http://doi.org/10.3109/09546634.2011.643221" target="_blank" rel="noreferrer noopener"&gt;10.3109/09546634.2011.643221&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63606">
                <text>Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="22886">
        <name>*Patient Satisfaction</name>
      </tag>
      <tag tagId="325">
        <name>2012</name>
      </tag>
      <tag tagId="28791">
        <name>Acne Vulgaris/*drug therapy/*psychology</name>
      </tag>
      <tag tagId="18158">
        <name>Adapalene</name>
      </tag>
      <tag tagId="149">
        <name>Adolescent</name>
      </tag>
      <tag tagId="36">
        <name>Adult</name>
      </tag>
      <tag tagId="28792">
        <name>Benzoyl Peroxide/administration &amp; dosage/*therapeutic use</name>
      </tag>
      <tag tagId="11">
        <name>Brodell Robert T</name>
      </tag>
      <tag tagId="18168">
        <name>Bucher Delphine</name>
      </tag>
      <tag tagId="37">
        <name>Child</name>
      </tag>
      <tag tagId="28793">
        <name>Dermatologic Agents/administration &amp; dosage/*therapeutic use</name>
      </tag>
      <tag tagId="4177">
        <name>Double-Blind Method</name>
      </tag>
      <tag tagId="2508">
        <name>Drug Combinations</name>
      </tag>
      <tag tagId="38">
        <name>Female</name>
      </tag>
      <tag tagId="8">
        <name>Humans</name>
      </tag>
      <tag tagId="18167">
        <name>Kerrouche Nabil</name>
      </tag>
      <tag tagId="24">
        <name>Male</name>
      </tag>
      <tag tagId="28794">
        <name>Naphthalenes/administration &amp; dosage/*therapeutic use</name>
      </tag>
      <tag tagId="22592">
        <name>Quality of Life/*psychology</name>
      </tag>
      <tag tagId="18163">
        <name>Rafal Elyse</name>
      </tag>
      <tag tagId="18162">
        <name>Schlosser Bethanee J</name>
      </tag>
      <tag tagId="1090">
        <name>Severity of Illness Index</name>
      </tag>
      <tag tagId="11048">
        <name>The Journal of dermatological treatment</name>
      </tag>
      <tag tagId="18164">
        <name>Toth Darryl</name>
      </tag>
      <tag tagId="18165">
        <name>Tyring Stephen</name>
      </tag>
      <tag tagId="18166">
        <name>Wertheimer Albert</name>
      </tag>
      <tag tagId="2106">
        <name>Young Adult</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
